Final oocyte maturation with two different GnRH agonists in antagonist co-treated cycles at risk of ovarian hyperstimulation syndrome

Reproductive BioMedicine Online ◽

10.1016/j.rbmo.2016.10.004 ◽

2017 ◽

Vol 34 (1) ◽

pp. 5-10 ◽

Author(s):

Yavuz Emre Şükür ◽

Batuhan Özmen ◽

Elif Didem Özdemir ◽

Mehmet Murat Seval ◽

Erkan Kalafat ◽

...

Keyword(s):

At Risk ◽

Oocyte Maturation ◽

Ovarian Hyperstimulation Syndrome ◽

Ovarian Hyperstimulation ◽

Gnrh Agonists ◽

Final Oocyte Maturation

Download Full-text

Implementing two strategies to avoid ovarian hyperstimulation syndrome (OHSS): use of GnRH agonists (GnRHa) to trigger final oocyte maturation associated with blastocyst cryopreservation

Fertility and Sterility ◽

10.1016/j.fertnstert.2013.07.244 ◽

2013 ◽

Vol 100 (3) ◽

pp. S517-S518

Author(s):

M.M. Carneiro ◽

A.L.M. Silva ◽

A.M.M. Cota ◽

J.P.J. Caetano

Keyword(s):

Oocyte Maturation ◽

Ovarian Hyperstimulation Syndrome ◽

Ovarian Hyperstimulation ◽

Gnrh Agonists ◽

Final Oocyte Maturation

Download Full-text

Recombinant vs. urinary human chorionic gonadotrophin (hCG) for triggering final oocyte maturation in patients at risk for ovarian hyperstimulation syndrome OHSS: a randomized clinical trial

10.26226/morressier.573c1514d462b80296c98c10 ◽

2016 ◽

Author(s):

Georgios Lainas

Keyword(s):

Clinical Trial ◽

At Risk ◽

Randomized Clinical Trial ◽

Oocyte Maturation ◽

Ovarian Hyperstimulation Syndrome ◽

Chorionic Gonadotrophin ◽

Human Chorionic Gonadotrophin ◽

Ovarian Hyperstimulation ◽

Final Oocyte Maturation ◽

Patients At Risk

Download Full-text

GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy?

Journal of Assisted Reproduction and Genetics ◽

10.1007/s10815-008-9198-1 ◽

2008 ◽

Vol 25 (2-3) ◽

pp. 63-66 ◽

Author(s):

S. Kol ◽

I. Solt

Keyword(s):

At Risk ◽

Oocyte Maturation ◽

Gnrh Agonist ◽

Ovarian Hyperstimulation Syndrome ◽

Ovarian Hyperstimulation ◽

Final Oocyte Maturation ◽

Patients At Risk

Download Full-text

The impact of using gonadotropin-releasing hormone agonist for triggering final oocyte maturation in antagonist-treated intracytoplasmic sperm injection cycles on women at high risk of developing ovarian hyperstimulation syndrome

Evidence Based Womenʼs Health Journal ◽

10.1097/01.ebx.0000482801.97372.5c ◽

2016 ◽

Vol 6 (3) ◽

pp. 85-89

Author(s):

Noura S. Elnassery ◽

Fouad A. Abuhamila

Keyword(s):

High Risk ◽

Oocyte Maturation ◽

Intracytoplasmic Sperm Injection ◽

Ovarian Hyperstimulation Syndrome ◽

Gonadotropin Releasing Hormone ◽

Ovarian Hyperstimulation ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Agonist ◽

Final Oocyte Maturation ◽

Download Full-text

Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting

Fertility and Sterility ◽

10.1016/j.fertnstert.2009.10.034 ◽

2010 ◽

Vol 94 (3) ◽

pp. 1111-1114 ◽

Author(s):

Andrea J. DiLuigi ◽

Lawrence Engmann ◽

David W. Schmidt ◽

Donald B. Maier ◽

John C. Nulsen ◽

...

Keyword(s):

High Risk ◽

Clinical Outcomes ◽

Oocyte Maturation ◽

Ovarian Hyperstimulation Syndrome ◽

Gonadotropin Releasing Hormone ◽

Ovarian Hyperstimulation ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Agonist ◽

Final Oocyte Maturation ◽

Download Full-text

Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a “freeze-all” strategy: a prospective multicentric study

Fertility and Sterility ◽

10.1016/j.fertnstert.2011.01.163 ◽

2011 ◽

Vol 95 (6) ◽

pp. 2029-2033.e1 ◽

Author(s):

Georg Griesinger ◽

Laura Schultz ◽

Thomas Bauer ◽

Anke Broessner ◽

Thorsten Frambach ◽

...

Keyword(s):

Oocyte Maturation ◽

Ovarian Hyperstimulation Syndrome ◽

Gonadotropin Releasing Hormone ◽

Ovarian Hyperstimulation ◽

Multicentric Study ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Agonist ◽

Final Oocyte Maturation ◽

Antagonist Protocol

Download Full-text

Ganirelix acetate causes a rapid reduction in estradiol levels without adversely affecting oocyte maturation in women pretreated with leuprolide acetate who are at risk of ovarian hyperstimulation syndrome*

Human Reproduction ◽

10.1093/humrep/del059 ◽

2006 ◽

Vol 21 (11) ◽

pp. 2830-2837 ◽

Author(s):

Robert L. Gustofson ◽

James H. Segars ◽

Frederick W. Larsen

Keyword(s):

At Risk ◽

Oocyte Maturation ◽

Ovarian Hyperstimulation Syndrome ◽

Leuprolide Acetate ◽

Ovarian Hyperstimulation ◽

Rapid Reduction ◽

Estradiol Levels

Download Full-text

IMPACT OF PROGESTERONE AND ESTRADIOL CONCENTRATION RATIO ON THE DAY OF FINAL OOCYTE MATURATION TRIGGER INJECTION ON PREGNANCY RATE AND OVARIAN HYPERSTIMULATION SYNDROME RISK IN WOMEN UNDERGOING VITRO FERTILIZATION

Journal of the Grodno State Medical University ◽

10.25298/2221-8785-2019-17-5-592-596 ◽

2019 ◽

Vol 17 (5) ◽

pp. 592-596

Author(s):

S. V. Zhukovskaya ◽

Keyword(s):

Pregnancy Rate ◽

Oocyte Maturation ◽

Ovarian Hyperstimulation Syndrome ◽

Concentration Ratio ◽

Ovarian Hyperstimulation ◽

Vitro Fertilization ◽

Final Oocyte Maturation ◽

Estradiol Concentration

Download Full-text

A comparison of Ovarian Hyperstimulation Syndrome (OHSS) parameters following different triggers of oocyte maturation during IVF Treatment

Endocrine Abstracts ◽

10.1530/endoabs.50.p352 ◽

2017 ◽

Author(s):

SA Clarke ◽

A Abbara ◽

R Islam ◽

L Jeffers ◽

G Christopoulos ◽

...

Keyword(s):

Oocyte Maturation ◽

Ovarian Hyperstimulation Syndrome ◽

Ovarian Hyperstimulation

Download Full-text

Do not dismiss the long downregulation protocol for women at risk of ovarian hyperstimulation syndrome (OHSS)

10.26226/morressier.573c1514d462b80296c98ca9 ◽

2016 ◽

Author(s):

Athanasios Papathanasiou

Keyword(s):

At Risk ◽

Ovarian Hyperstimulation Syndrome ◽

Ovarian Hyperstimulation

Download Full-text